Andersen, Jan Terje; Foss, Stian; Kenanova, Vania E et al. (2012) Anti-carcinoembryonic antigen single-chain variable fragment antibody variants bind mouse and human neonatal Fc receptor with different affinities that reveal distinct cross-species differences in serum half-life. J Biol Chem 287:22927-37
|
Stern, D M; Esposito, C; Gerlach, H et al. (1991) Endothelium and regulation of coagulation. Diabetes Care 14:160-6
|
Cozzolino, F; Torcia, M; Aldinucci, D et al. (1990) Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci U S A 87:6487-91
|
Clauss, M; Murray, J C; Vianna, M et al. (1990) A polypeptide factor produced by fibrosarcoma cells that induces endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin. J Biol Chem 265:7078-83
|
Gerlach, H; Esposito, C; Stern, D M (1990) Modulation of endothelial hemostatic properties: an active role in the host response. Annu Rev Med 41:15-24
|
Brett, J; Gerlach, H; Nawroth, P et al. (1989) Tumor necrosis factor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving regulatory G proteins. J Exp Med 169:1977-91
|
May, L T; Torcia, G; Cozzolino, F et al. (1989) Interleukin-6 gene expression in human endothelial cells: RNA start sites, multiple IL-6 proteins and inhibition of proliferation. Biochem Biophys Res Commun 159:991-8
|
Esposito, C; Gerlach, H; Brett, J et al. (1989) Endothelial receptor-mediated binding of glucose-modified albumin is associated with increased monolayer permeability and modulation of cell surface coagulant properties. J Exp Med 170:1387-407
|
Gerlach, H; Lieberman, H; Bach, R et al. (1989) Enhanced responsiveness of endothelium in the growing/motile state to tumor necrosis factor/cachectin. J Exp Med 170:913-31
|
Nawroth, P; Handley, D; Matsueda, G et al. (1988) Tumor necrosis factor/cachectin-induced intravascular fibrin formation in meth A fibrosarcomas. J Exp Med 168:637-47
|
Showing the most recent 10 out of 12 publications